Motor, Respiratory, and Bulbar Function 4 Years After Nusinersen Treatment in Patients With Type I Spinal Muscular Atrophy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar function
Eur. J. Neurol. 2023 Jun 01;30(6)1755-1763, M Pane, G Coratti, VA Sansone, S Messina, M Catteruccia, C Bruno, M Sframeli, E Albamonte, M Pedemonte, N Brolatti, I Mizzoni, A D'Amico, C Bravetti, B Berti, C Palermo, D Leone, F Salmin, R De Sanctis, MC Pera, M Piastra, O Genovese, F Ricci, I Cavallina, R Masson, R Zanin, C Agosto, E Salomon, I Bruno, A Magnolato, E Bertini, FD Tiziano, F Bovis, E MercuriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.